Combination Therapy May Increase Lesion Closure in PCV - Quiz - MDSpire

Combination Therapy May Increase Lesion Closure in PCV

The combination of photodynamic therapy and intravitreal  aflibercept did not improve 1-year visual acuity outcomes compared with aflibercept monotherapy.

  • By

  • Andrea Surnit

  • May 13, 2026

  • 3 min

Share

Original Source(s)

Combination Therapy May Increase Lesion Closure in PCV

  • by Andrea Surnit

  • May 13, 2026

Related Content

Highlights From Atlantic Coast Retina Club and Macula 2026

Renowned ophthalmologists gathered in Philadelphia to discuss groundbreaking strategies and cases at the Atlantic Coast Retina Club and Macula 2026 conference.

Educating Patients on IOL Options Is Key

Stone Oak Ophthalmology Center strives to provide an environment in which patients fully understand their options and feel confident with their IOL choices.

FDA Approves Lucentis Biosimilar Nufymco

Ranibizumab-leyk (Nufymco) is approved for all Lucentis indications.